enGene Holdings Inc.
ENGN
$12.17
$1.5314.38%
NASDAQ
| 10/31/2025 | 07/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 5.25% | 6.61% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 31.84% | 10.41% | |||
| Operating Income | -31.84% | -10.41% | |||
| Income Before Tax | -33.48% | -12.42% | |||
| Income Tax Expenses | -307.95% | -0.42% | |||
| Earnings from Continuing Operations | -30.66% | -12.30% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -30.66% | -12.30% | |||
| EBIT | -31.84% | -10.41% | |||
| EBITDA | -31.84% | -10.36% | |||
| EPS Basic | -29.93% | -12.13% | |||
| Normalized Basic EPS | -32.73% | -12.26% | |||
| EPS Diluted | -29.93% | -12.13% | |||
| Normalized Diluted EPS | -32.73% | -12.26% | |||
| Average Basic Shares Outstanding | 0.56% | 0.15% | |||
| Average Diluted Shares Outstanding | 0.56% | 0.15% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||